Biostate AI Builds Global RNA-AI Pipeline With $12M Boost, Ventures In China And India

Patented Wet-Lab Technologies Can Slash RNA-Seq Costs To Under $20 Per Sample

Bayosthiti, Biostate AI's Indian subsidiary, focuses on developing precision cancer diagnostics specifically tailored to the Indian population. Picture Courtesy: Biostate AI

More from Diagnostics

More from Device Area